Alerts will be sent to your verified email
Verify Email
RUBICON
Insufficient data
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Rubicon Research is an integrated pharmaceutical company with business encompassing the entire value chain in the research, development and production of pharmaceutical products. Further, the company has robust sales and distribution capabilities in the US.
Rubicon Research major competitors are Sun Pharma Inds., Aurobindo Pharma, Zydus Lifesciences, Strides Pharma Scien, Dr. Reddy's Lab, Alembic Pharma, Lupin.
Market Cap of Rubicon Research is ₹0 Crs.
While the median market cap of its peers are ₹88,644 Crs.
Rubicon Research seems to be less financially stable compared to its competitors.
Altman Z score of Rubicon Research is 0 and is ranked 8 out of its 8 competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | ||||||||||||||||||
| Investor Presentation | ||||||||||||||||||
| Conference Call | ||||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
